News

2020

HAI Releases Annual Report 2019

Clinical trials and COVID-19

Reflections on the World Health Assembly

COVID-19 And Its Far-Reaching Health Impacts in Sub-Saharan Africa

Why TRIPS flexibilities are a crucial mechanism for access to medicines

EU Must Not Miss its Chance on WHO Technology Pool

TRIPS-flexibilities in Health Crises and Beyond

In defence of WHO

The hidden impact of COVID-19 on sexual and reproductive health

Community measures to prevent snakebite during COVID-19

Reversed gains in the advancement of SRHR in Kenya; effects of COVID-19

To tackle COVID-19 pandemic, transparency and collaboration are vital

COVID-19, social determinants and frontline workers

Health Action International Working from Home

Ensure transparency, affordability and availability of vaccines and treatments for COVID-19, say MEPs

HAI Follows Dutch Government Advice in Response to COVID-19

HAI Recognised for Commitment to Gender Equality

Europe’s Beating Cancer Plan

Niets magisch aan medicijnprijzen

Nothing magical about medicine prices

US puts pressure on the Netherlands over compulsory licenses

A busy week at the Court of Justice of the European Union

2019

How to measure change in EU Policy

Health Technology Assessments: will 2020 end the deadlock?

Is clinical trial transparency under threat?

Statement from the ACCISS Study regarding the WHO announcement of the first-ever insulin prequalification programme

REBRAND: Fact or Fiction publication

An insightful day at the EURIPID stakeholder meeting in Budapest

Halving snakebite deaths and disabilities by 2030 – How can we reach WHO’s goal?

Gender mainstreaming, sustainability and the future of HSA: Partners gather in Kenya for the JAP 2019